期刊文献+

神经肽Y对人血管平滑肌细胞脂质代谢的调制作用 被引量:3

The Changes of Lipid Metabolism in Human Vascular Smooth Muscle Cells Induced by Neuropeptide Y
下载PDF
导出
摘要 为探讨神经肽Y在血管平滑肌细胞中对脂质代谢是否具有调制作用 ,以成人血管平滑肌细胞体外培养模型为研究对象 ,经不同浓度的神经肽Y作用后 ,运用激光扫描共聚焦显微镜和免疫荧光组织化学技术 ,定量观察神经肽Y对人血管平滑肌细胞的低密度脂蛋白受体表达的影响。结果发现 ,对照组人血管平滑肌细胞的低密度脂蛋白受体表达的平均荧光强度为 2 4 4 3± 1 89,而在浓度为 1 0 8mol L、1 0 7mol L、1 0 6mol L和 1 0 5mol L的神经肽Y作用下 ,各组的平均荧光强度分别为 2 0 1 5± 1 64、1 890± 1 4 5、1 841± 1 2 3和 1 786± 1 36 ,与对照组相比分别下降了1 7.49%、2 2 .62 %、2 4 .64 %和 2 6 .92 % (P <0 .0 1 ) ,且各浓度组之间多有显著差异 ,呈现一定的剂量依赖效应。结果提示 ,神经肽Y很可能通过下调人血管平滑肌细胞低密度脂蛋白受体的表达 ,从而影响血管平滑肌细胞的脂质代谢。 Aim To explore the effect of neuropeptide Y on lipid metabolism in human vascular smooth muscle cells. Methods The human vascular smooth muscle cell culture model was used for experiments. The expression of low density lipoprotein receptor in cultured human vascular smooth muscle cells were quantitatively assayed by the immunofluorescent staining under laser scanning confocal micropscope. Results The averaged fluorescent value in control group was 2443±189,while the values in neuropeptide Y groups were 2015±164,1890±145,1841±123 and 1786±136,decreasing by 26.92%, 24.64%, 22.62% and 17.49%(P<0.01),respectively in 10 8 mol/L, 10 7 mol/L, 10 6 mol/L and 10 5 mol/L concentrations of neuropeptide Y, compared with control group. There was significant differences among the different concentrations neuropeptide Y groups in a dose dependent manner. Conclusion Neuropeptide Y may influence the lipid metabolism of human vascular smooth cells by downregulating low density lipoprotein receptor in human vascular smooth muscle cells.
出处 《中国动脉硬化杂志》 CAS CSCD 2002年第3期210-213,共4页 Chinese Journal of Arteriosclerosis
基金 广东省自然科学基金 ( 980 4 6 6 ) 广州医学院科研基金( 990 7)资助
关键词 神经肽Y 人血管平滑肌细胞 脂质代谢 调制作用 动脉粥样硬化 Neuropeptide Y Muscle, Smooth, Vascular Lipids/metabolism Receptors, LDL Atherosclerosis
  • 相关文献

参考文献6

二级参考文献14

共引文献45

同被引文献29

  • 1姚红,黄少华,苏子仁.葛根总黄酮对离体神经肽Y诱导的心肌细胞肥大的影响[J].中国病理生理杂志,2004,20(7):1283-1285. 被引量:2
  • 2吴开云.毁损弓状核后血清中不同成分及一氧化氮和脂质过氧化物的变化[J].解剖学报,2005,36(2):212-213. 被引量:6
  • 3[1]Allen AS, Adrain TE, Allen JM et al. Neuropeptide Y: Distribution in the rat brain. Science, 1983;221(26):877~9
  • 4[2]Unsitupa MI, Karvonen MK, Pesoen U et al. Neuropeptide Y: a novel like between the neuroendocrine system and cholesterol metabolism. Ann Med, 1998;30(6):508~10
  • 5[3]Beck B. Neuropeptides and obesity. Nutrition, 2000;16(10):916~23
  • 6[4]Billington CJ, Briggs JE, Harker S et al. Neuropeptide Y in hypothalamic paraventricular nucleus; a center coordinating energy metabolism. Am J Physiol,1994,266(Regulatory Integrative Comp Physiol 35):R1765~70
  • 7[5]Zarjevski N, Cusin I, Vettor R et al. Chronic intracerebroventricular neuropeptide Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology,1993;133(4);1753~8
  • 8吴开云,高摄渊.损毁弓状核对总胆固醇、高密度脂蛋白、氧化性低密度脂蛋白的影响[J].中国学术期刊文摘,1998,4(10):1256-7.
  • 9[7]Dryden S, Lucy P, Helen M et al. Increased neuropeptide Y secretion in Paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res, 1995;690(2);185~8
  • 10[9]Petter M, Ahren B, Lundquist I et al. Neuropeptide Y intrapancreatic neuronal localization and effects on insulin secretion in the mouse. Cell Tissue Res,1987(1);248:43~8

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部